You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Drug Price Trends for NDC 23155-0604


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 23155-0604

Drug NameNDCPrice/Unit ($)UnitDate
MODAFINIL 100 MG TABLET 23155-0604-09 0.30620 EACH 2025-03-19
MODAFINIL 100 MG TABLET 23155-0604-03 0.30620 EACH 2025-03-19
MODAFINIL 100 MG TABLET 23155-0604-09 0.27795 EACH 2025-02-19
MODAFINIL 100 MG TABLET 23155-0604-03 0.27795 EACH 2025-02-19
MODAFINIL 100 MG TABLET 23155-0604-09 0.24017 EACH 2025-01-22
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Best Wholesale Price for NDC 23155-0604

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for Modafinil (NDC: 23155-0604)

Overview of Modafinil

Modafinil, marketed under the NDC code 23155-0604 by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., is a prescription medication used to treat conditions such as narcolepsy, shift work sleep disorder, and obstructive sleep apnea. It is a central nervous system stimulant that helps increase alertness and wakefulness.

Current Market Trends

Prescription Drug Costs and Shift to OTC

The high cost of prescription drugs is a significant factor influencing the pharmaceutical market. According to a study by the Kaiser Family Foundation, nearly one in three US individuals does not take medication as prescribed due to the high cost of drugs. This has led to a shift towards over-the-counter (OTC) drugs, but since modafinil is a prescription-only medication, its market is less affected by this trend[4].

Price Increases in Prescription Drugs

In 2022, over 1,216 prescription drugs experienced price hikes, with some increasing by more than 500%. However, the specific price trends for modafinil are not detailed in these reports. Generally, generic drugs have seen significant price increases, but modafinil, being a branded and generic drug, may have different pricing dynamics[2].

Market Size and Growth

U.S. Prescription Drug Market

The U.S. prescription drug market is vast and growing, but the specific segment for modafinil is part of a larger market. The overall U.S. prescription drug market is influenced by factors such as research and development costs, regulatory approvals, and patient demand.

Generic Competition

Modafinil has generic versions available, which can impact its market share and pricing. Generic competition often leads to lower prices as multiple manufacturers enter the market. Heritage Pharmaceuticals Inc., as a generic drug manufacturer, would need to navigate this competitive landscape to maintain market share[5].

Price Projections

Historical Pricing

There is no specific historical pricing data available for modafinil under the NDC code 23155-0604 in the provided sources. However, it is common for generic drugs to experience price stability or slight decreases over time due to increased competition.

Future Pricing Trends

Given the general trend of prescription drug price increases, modafinil prices might see moderate increases. However, the extent of these increases would depend on various factors such as production costs, regulatory changes, and market competition.

Regulatory and Technological Impacts

Regulatory Changes

Regulatory shifts can significantly impact drug pricing. Stricter regulations on patient data and drug safety, as well as transparency in drug pricing, could influence the cost of modafinil. Companies must be prepared to adapt to these changes to maintain their market position[3].

Technological Advancements

Technological advancements, such as AI in drug development and supply chain management, can reduce costs and improve efficiency. However, these advancements are more likely to impact the development of new drugs rather than the pricing of existing medications like modafinil[3].

Consumer Behavior and Demand

Patient Compliance

High prescription drug costs can lead to non-compliance, as patients may opt for cheaper alternatives or skip doses. For modafinil, patient compliance is crucial, and any significant price increase could affect demand negatively[4].

Market Demand

The demand for modafinil is driven by the prevalence of sleep disorders and the need for effective treatments. As the population ages and lifestyle factors contribute to sleep issues, the demand for modafinil is likely to remain stable or increase.

Key Takeaways

  • Market Trends: The high cost of prescription drugs is driving a shift towards OTC alternatives, but modafinil remains a prescription-only drug.
  • Price Increases: Generic drugs have seen significant price hikes, but modafinil's pricing trends need specific data for accurate projections.
  • Regulatory Impact: Regulatory changes on patient data and drug safety could influence modafinil's pricing.
  • Technological Advancements: While AI and other technologies are transforming drug development, their immediate impact on modafinil pricing is minimal.
  • Consumer Behavior: Patient compliance is crucial, and significant price increases could affect demand.

FAQs

  1. What is the current market size for modafinil in the U.S.?

    • The specific market size for modafinil is not provided in the sources, but it is part of the larger U.S. prescription drug market.
  2. How does generic competition affect modafinil pricing?

    • Generic competition typically leads to lower prices due to increased market competition.
  3. What are the key factors driving the U.S. prescription drug market?

    • Key factors include research and development costs, regulatory approvals, patient demand, and the high cost of prescription drugs.
  4. How might regulatory changes impact modafinil pricing?

    • Regulatory changes on patient data and drug safety could influence pricing by imposing additional costs or transparency requirements.
  5. What role does AI play in the pharmaceutical industry, and how might it affect modafinil?

    • AI is transforming drug development by reducing costs and speeding up the process, but its immediate impact on modafinil pricing is minimal.

Sources

  1. DailyMed - OCTREOTIDE ACETATE injection, solution
  2. Oregon's Drug Price Transparency Program
  3. The Future of Pharma: 2025's Key Trends To Know
  4. U.S. OTC Drugs Market Forecast Report 2024-2029
  5. Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.